Blood coagulation and autologous blood transfusion in cardiac surgery.
暂无分享,去创建一个
[1] S. Stenbjerg,et al. Heparin levels and activated clotting time (ACT) during open heart surgery. , 2009, Scandinavian journal of haematology.
[2] D. Collen. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? , 1990, Annals of internal medicine.
[3] A Ranhosky,et al. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. , 1990, Circulation.
[4] A. Keats,et al. Low activated coagulation time during cardiopulmonary bypass does not increase postoperative bleeding. , 1990, The Annals of thoracic surgery.
[5] M. Schechter,et al. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. , 1989, The New England journal of medicine.
[6] L. Goodnough,et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. , 1989, The New England journal of medicine.
[7] F. Claas,et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. , 1989, The New England journal of medicine.
[8] J. Branch,et al. HEPARIN SENSITIVITY COMPARISON OF THE ACT, SCT, AND APTT , 1989 .
[9] H. White,et al. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. , 1989, The New England journal of medicine.
[10] H. Reichenspurner,et al. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. , 1989, The Journal of thoracic and cardiovascular surgery.
[11] T. Lane,et al. Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. , 1989, The Annals of thoracic surgery.
[12] D. Cosgrove,et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.
[13] L. Edmunds,et al. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.
[14] W. Dietrich,et al. Reduction of blood utilization during myocardial revascularization. , 1989, The Journal of thoracic and cardiovascular surgery.
[15] N. Starr,et al. Heparin-associated thrombocytopenia: management of patients for open heart surgery. Case reports describing the use of iloprost. , 1988, Anesthesiology.
[16] D. Bichet,et al. 1-Desamino[8-D-Arginine]Vasopressin (dDAVP) Decreases Blood Pressure and Increases Pulse Rate in Normal Individuals , 1988, Thrombosis and Haemostasis.
[17] J. Kauten,et al. Revascularization after thrombolytic therapy for acute myocardial infarction: an analysis of 573 patients. , 1988, The Annals of thoracic surgery.
[18] R. Weisel,et al. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. , 1988, The Journal of thoracic and cardiovascular surgery.
[19] J. Spivak,et al. Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. , 1988, JAMA.
[20] J. Paramo,et al. Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? , 1988, Circulation.
[21] G. Gravlee,et al. Variability of the activated coagulation time. , 1988, Anesthesia and analgesia.
[22] J. Caprini,et al. Decreased Platelet Number and Function and Increased Fibrinolysis Contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients , 1988, Thrombosis and Haemostasis.
[23] L. Muhlbaier,et al. Immediate versus delayed coronary grafting after streptokinase treatment. Postoperative blood loss and clinical results. , 1988, The Journal of thoracic and cardiovascular surgery.
[24] L. Goodnough,et al. Autologous blood donation for elective surgery. Effect on physician transfusion behavior. , 1987, JAMA.
[25] W. van Oeveren,et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.
[26] C. Akins,et al. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. , 1987, The Journal of thoracic and cardiovascular surgery.
[27] G. Gravlee,et al. Predicting the pharmacodynamics of heparin: a clinical evaluation of the Hepcon System 4. , 1987, Journal of cardiothoracic anesthesia.
[28] H. Kreuzer,et al. Influence of heparin, aspirin, streptokinase and factor VIII (AHF) on amorphous electron-dense substance, a mediator of platelet and thrombus adhesion in vivo. , 1987, Haemostasis.
[29] J. Lowe,et al. Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery. , 1987, The Annals of thoracic surgery.
[30] W. Daggett,et al. Transfusion of predonated autologous blood in elective cardiac surgery. , 1987, The Annals of thoracic surgery.
[31] T. Bateman,et al. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. , 1987, Journal of the American College of Cardiology.
[32] R. Strauss,et al. Predeposited autologous blood for elective surgery. A national multicenter study. , 1987, The New England journal of medicine.
[33] C. Fisher,et al. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function. , 1987, The Journal of laboratory and clinical medicine.
[34] R. Weintraub,et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. , 1986, The New England journal of medicine.
[35] P. Belcher,et al. Reduction of blood use in surgery for coronary artery disease. , 1986, The Journal of cardiovascular surgery.
[36] E. E. Glazer,et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program , 1986, Transfusion.
[37] R. Weintraub,et al. Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery , 1986 .
[38] R. S. Mitchell,et al. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. , 1986, The Journal of thoracic and cardiovascular surgery.
[39] C. Fisher,et al. THE USE OF ILOPROST(ZK36374) TO PERMIT CARDIOPULMONARY BYPASS IN 2 PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA , 1985 .
[40] R. Wilson,et al. Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.
[41] R. Bick. Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal Circuits , 1985, Seminars in thrombosis and hemostasis.
[42] L. Brace,et al. An Objective Assessment of the Interaction of Heparin and Its Fractions with Human Platelets , 1985, Seminars in thrombosis and hemostasis.
[43] L. Cohn,et al. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization. , 1984, The Annals of thoracic surgery.
[44] G. Chung,et al. Fresh frozen plasma: a solution to heparin resistance during cardiopulmonary bypass. , 1984, The Annals of thoracic surgery.
[45] M. Cheang,et al. SHORTENING OF BLEEDING TIME BY 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN VARIOUS BLEEDING DISORDERS , 1984, The Lancet.
[46] S. Phillips,et al. Immediate coronary bypass following failed streptokinase infusion in evolving myocardial infarction. , 1984, The Journal of thoracic and cardiovascular surgery.
[47] B. Bull,et al. Platelet Involvement in the Activated Coagulation Time of Heparinized Blood , 1984, Anesthesia and analgesia.
[48] J. A. Cohen. Activated Coagulation Time Method for Control of Heparin is Reliable during Cardiopulmonary Bypass , 1984, Anesthesiology.
[49] R. Weinstein,et al. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. , 1984, The New England journal of medicine.
[50] F. Hehrlein,et al. Prostacyclin in aortocoronary bypass surgery: a double-blind, placebo-controlled study. , 1983, Thrombosis research.
[51] J. Ankeney,et al. Activated Coagulation and Activated Partial Thromboplastin Times in Assessment and Reversal of Heparin‐Induced Anticoagulation for Cardiopulmonary Bypass , 1983, Anesthesia and analgesia.
[52] D. Goldfinger,et al. Safety of autologous blood donation prior to elective surgery for a variety of potentially “high‐risk” patients , 1983, Transfusion.
[53] S. Thomas,et al. Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment. , 1983, The Journal of thoracic and cardiovascular surgery.
[54] D. Silver,et al. Heparin-induced thrombocytopenia with thrombosis and hemorrhage. , 1981, Archives of surgery.
[55] M. G. Lötter,et al. Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.
[56] H. Takahashi. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease. , 1981, Thrombosis research.
[57] Packham Ma,et al. Pharmacology of platelet-affecting drugs. , 1980 .
[58] E. Hessel,et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.
[59] H. Soloway,et al. Heparin anticoagulation during cardiopulmonary bypass in an antithrombin-III deficient patient. Implications relative to the etiology of heparin rebound. , 1980, American journal of clinical pathology.
[60] C. J. Lambert,et al. The Treatment of Postperfusion Bleeding Using ε-Aminocaproic Acid, Cryoprecipitate, Fresh-Frozen Plasma, and Protamine Sulfate , 1979 .
[61] F. Loop,et al. Blood conservation during myocardial revascularization. , 1979, The Annals of thoracic surgery.
[62] R. Colman,et al. Preservation of Human Platelets with Prostaglandin Ei during in Vitro Simulation of Cardiopulmonary Bypass , 1979, Circulation research.
[63] C. Kisker,et al. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. , 1978, The Annals of thoracic surgery.
[64] T. Barrowcliffe,et al. Antithrombin III and heparin. , 1978, British medical bulletin.
[65] J. Verska. Control of heparinization by activated clotting time during bypass with improved postoperative hemostasis. , 1977, The Annals of thoracic surgery.
[66] F. Bachmann,et al. The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.
[67] F. Bachmann,et al. The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.
[68] B. Bull,et al. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. , 1975, The Journal of thoracic and cardiovascular surgery.
[69] B. Bull,et al. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. , 1975, The Journal of thoracic and cardiovascular surgery.
[70] N. Mills,et al. Fresh Autologous Blood Transfusions with Extracorporeal Circulation , 1973, Annals of surgery.
[71] M. Buckley,et al. Transfusion of fresh autologous blood in open-heart surgery. A method for reducing bank blood requirements. , 1972, The Journal of thoracic and cardiovascular surgery.
[72] P. Hattersley. Activated coagulation time of whole blood. , 1966, JAMA.
[73] S. Effert,et al. Late results after intracoronary thrombolysis and early bypass grafting for acute myocardial infarction. , 1989, The Journal of thoracic and cardiovascular surgery.
[74] G. Gravlee,et al. Early anticoagulation peak and rapid distribution after intravenous heparin. , 1988, Anesthesiology.
[75] S. Ferraris,et al. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. , 1988, The Annals of thoracic surgery.
[76] G. Taylor,et al. Early operative intervention after thrombolytic therapy for acute myocardial infarction. , 1985, Journal of vascular surgery.
[77] M. Laato,et al. Use of activated clotting time to monitor anticoagulation during cardiac surgery. , 1984, Scandinavian journal of thoracic and cardiovascular surgery.
[78] 高橋 芳右. Studies on the pathophysiology and treatment of von Willebrand's disease , 1984 .
[79] F. Spencer,et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. , 1981, Annals of surgery.
[80] M. Orr. Autotransfusion: the use of washed red cells as an adjunct to component therapy. , 1978, Surgery.
[81] N. Baumslag. Letter: Lead poisoning. , 1975, Lancet.